Treatment paradigms for treatment-resistant schizophrenia

Lancet Psychiatry. 2024 Jul;11(7):488-489. doi: 10.1016/S2215-0366(24)00173-1.

Authors

Carol Lim¹, Abigail L Donovan²

Affiliations

¹ Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Electronic address: [email protected].
² Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

PMID: 38879270
DOI: 10.1016/S2215-0366(24)00173-1

No abstract available

Publication types

Comment

MeSH terms

Antipsychotic Agents* / therapeutic use
Humans
Schizophrenia / therapy
Schizophrenia, Treatment-Resistant / drug therapy
Schizophrenia, Treatment-Resistant / therapy

Substances

Antipsychotic Agents